Search Results for:

Economic Costs of the Opioid Crisis for Employers

A considerable portion of the nearly $631 billion dollars in economic costs (estimated total US costs from 2015-2018) of the opioid crisis is borne by employers, including increased spending on health care and lost productivity. To better manage their financial risks and improve the health of their employees, employers should consider strategies that encompass both preventative and supportive measures to help those experiencing opioid use disorder (OUD) better manage their conditions and move toward recovery.

Read More

Milliman Report Released

Study results reveal individuals with both behavioral and physical health conditions see little spending on behavioral health treatment.

Read More

The State of the Opioid Crisis in Florida and a Comprehensive Alternative Treatment Approach for Substance Use Disorder

This two-hour session opened with Sheriff Dennis Lemma, a state and national leader fighting the opioid crisis, followed by an expert panel discussion on comprehensive and effective addiction recovery.

Read More

Trends and Policy Changes in the Drug Value Chain: Five Employer Actions and Recommendations

This two-hour session featured industry veteran Alex Jung, MBA, Partner & Managing Director of EY-Parthenon, who covered trends and policy changes in the drug value chain.

Read More